Skip to main content
Ipsen Home Page
Press shift tab to select search category
Loading...
  • Newsroom arrow down
      < Back
    • Newsroom
    • Press Releases
    • Media Updates
    • Media Resources
    • Media Contacts
    • Subscribe
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports & Regulated Information
    • Investor Events & Financial Calendar
    • Shareholder Information
    • Subscribe
    • Ratings & Bonds
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
    • Job Search
  • Contacts arrow down
      < Back
    • Contacts
    • Contacts
    • Our Locations
    • Report Side Effects
    • Subscribe
  • Press shift tab to select search category
    Loading...
  •         EN  arrow_down
    • English EN
    • Français FR
  •  Global
    <
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
    • UAE & Gulf
    • Saudi Arabia
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Expertise
      < Back
    • Expertise
    • Oncology
    • Rare Disease
    • Neuroscience
    • Medicines
  • Science
      < Back
    • Science
    • Science
        < Back
      • Science
      • Oncology
      • Rare Disease
      • Neuroscience
    • Profiles
    • Partnering
        < Back
      • Partnering
      • Therapeutic focus
      • Meet the team
    • Clinical Trials
        < Back
      • Clinical Trials
      • Lay Summaries
      • Find Clinical Trials
    • Pipeline
  • Sustainability
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patients
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories
  1. Home
  2. Press Releases
  3. Shareholders Meeting press releases

Ipsen – 2021 SM – Results and replay – 31 May 2021

Post navigation

Previous
Next

Ipsen – 2021 SM – Results and replay – 31 May 2021

Ipsen – 2021 SM – Results and replay – 31 May 2021

- 09 June 2021 - 0 mins read

Post navigation

Previous
Next
Related Documents
  • Ipsen 2021 SM Results 31 May 2021 1   Download  (165 KB)
  • Replay SM VA 2021   Download  (107 KB)
Related links
  • Watch the replay    Watch the replay Open in new tab
Related stories
04 March 2026 0 mins read

Ipsen 2026 Annual General Meeting
17 April 2025 0 mins read

Ipsen 2025 Annual General Meeting
29 April 2024 0 mins read

2024 Annual General Meeting
See more stories

Related Press Releases

13 May 2026

Ipsen S.A. – Evolution of the composition of the Board...
13 May 2026

Annual General Meeting of Ipsen S.A. held on 13 May...
22 April 2026

Ipsen S.A. – Information relating to the holding of the...
21 May 2025

Ipsen S.A. – Annual General Meeting held on 21 May...
30 April 2025

Ipsen S.A. – Formalities for making available and consulting preparatory...
28 May 2024

Annual General Meeting of Ipsen S.A. held on 28 May...
01 June 2023

Combined Shareholders’ Meeting of Ipsen S.A. held on 31 May...
31 May 2023

Description of the regulatory framework of the share repurchase program...
03 June 2022

IPSEN – 2022 SM – Voting results and replay
05 May 2021

Combined Shareholders’ Meeting of 27 May 2021

IPN price

€166.00

 €0.80 (0.48%)

  • Media Resources
  • Annual Report
  • Contacts
  • Our Locations
Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

© Ipsen Pharma. All rights reserved - 2026

You are now leaving the Ipsen group global website. To continue, please click on Continue?

Continue
We value your feedback

How easy was it to navigate Ipsen website and locate the information you were seeking?